Sarepta Therapeutics Q2 2024 Adj. EPS $0.44 Beats $0.01 Estimate, Sales $362.931M Miss $391.406M Estimate
Author: Benzinga Newsdesk | August 07, 2024 04:09pm
Sarepta Therapeutics (NASDAQ:
SRPT) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.01 by 4300 percent. The company reported quarterly sales of $362.931 million which missed the analyst consensus estimate of $391.406 million by 7.28 percent. This is a 38.93 percent increase over sales of $261.238 million the same period last year.
Posted In: SRPT